Navigation Links
China Medicine Corporation Holds Annual General Meeting of Shareholders
Date:5/20/2009

GUANGZHOU, China, May 20 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (''China Medicine'' or ''the Company''), a developer and leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (''TCM''), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China (''PRC''), announced that it held its Annual Meeting of Shareholders (the ''AMS'') on May 19th, 2009, in New York City.

At the meeting, a proposal to change the Company's domicile from Delaware to Nevada pursuant to a plan of merger, as set out in the Company's proxy statement, was approved by a majority of shares outstanding and entitled to vote. In addition, a proposal for the election of five directors to serve until the AMS in 2010 was also approved by a majority of shares present at the meeting, by proxy or in person, and entitled to vote. Specifically, shareholders elected Mr. Senshan Yang, Ms. Minhua Liu, Mr. Robert Adler, Ms. Rachel Gong, and Mr. Yanfang Chen as members of the Board of Directors of the Company.

About China Medicine Corporation

China Medicine Corporation is a developer and leading distributor of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine also has its research and development force for certain products it manufactures through OEM arrangement and distributes. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

    Company Contact:

     Ms. Huizhen Yu
     Chief Financial Officer
     China Medicine Corp
     Tel:   +86-20-8739-1718
     Email: konzern08@163.com

    Investor Relations Contact:
     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915 (NY Office)
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009
2. China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan
3. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
4. China and the Netherlands join forces for research into water management
5. China Sky One Medical, Inc. Announces Record First Quarter 2009 Results
6. China Medicine Announces First Quarter 2009 Results
7. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
8. Jiangbo Pharmaceuticals, Inc. to Present at CCG IRs China Rising Conference in New York
9. China Nepstar Chain Drugstore to Announce First Quarter 2009 Financial Results on Wednesday, May 27, 2009
10. New study reveals the financial effects of stroke in China
11. China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology: